India's Jeena Sikho Lifecare gains after approval for clinical trials

Jeena Sikho Lifecare

08/09/2025 10:00

** Shares of Jeena Sikho Lifecare JEEN.NS rise 4.5% to 805 rupees

** Pharma co gets approval for clinical trial on four products - anti-diabetes efficacy of SDM02 tablets, Shuddhi XS syrup, Petshuddhi Churna, and Shuddhi Dr. B P Care tablets

** Outcomes of the studies are expected to support future product validation - JEEN

** JEEN up nearly 89% YTD

 (Reporting by Vijay Malkar)

 ((VijayDattaram.Malkar@thomsonreuters.com;))